IRIS
GIACOBBE, DANIELE ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.644
Totale 11.644
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 11.644
Totale 11.644
Salva come PNG Salva come JPEG
Città #
Genova 6.872
Genoa 2.020
Rapallo 1.994
Vado Ligure 680
Bordighera 78
Totale 11.644
Salva come PNG Salva come JPEG
Nome #
Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy 242
Emergence of a KPC-3-Producing Escherichia coli ST69 as a Cause of Bloodstream Infections in Italy 181
Initial serum (1,3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil 163
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 159
Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir. 153
Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area 137
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: Findings from a multicenter prospective observational study 136
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery 135
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 134
Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study 132
Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia? Authors' response 128
Use of colistin in adult patients: a cross-sectional study 125
Commentary: Human Immunodeficiency Virus and Allergic Bronchopulmonary Aspergillosis 122
Increasing incidence of Clostridium difficile infections: results from a 5-year retrospective study in a large teaching hospital in the Italian region with the oldest population 122
Will new antimicrobials overcome resistance among Gram-negatives? 121
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 120
Early carbapenem-resistant Klebsiella pneumoniae bacteraemia: should we expand the screening? 120
Management of KPC-producing Klebsiella pneumoniae infections 117
Incidence and outcome of invasive candidiasis in intensive care units (icus) in europe: Results of the eucandicu project 117
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis 116
Regional point prevalence study of healthcare-associated infections and antimicrobial use in acute care hospitals in Liguria, Italy 113
Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: should we get to the PK/PD root of the paradox? 112
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 112
Treatment of Infections Due to MDR Gram-Negative Bacteria 110
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies 110
Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A 8-year retrospective study in a large teaching hospital in northern Italy 109
The Beta-d-glucan Test: Time to Re-Visit Its Utility in IFI Diagnosis 109
Post-operative abdominal infections: epidemiology, operational definitions, and outcomes 108
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 106
null 102
Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia 102
Risk factors andmortality of healthcare-associated and community-acquired Staphylococcus aureusbacteraemia 99
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from multicenter case-control-control-study. 99
Respiratory Fungal Diseases in Adult Patients With Cystic Fibrosis 99
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients with Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae 97
Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor 95
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 94
Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery 93
Ceftolozane/tazobactam: place in therapy 91
Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment 90
Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review 88
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 87
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals 85
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 85
The role of fosfomycin for multidrug-resistant gram-negative infections 85
New insights into infections due to multidrug resistant gram negative bacteria: The interplay between lab and clinic 84
Ceftobiprole: drug evaluation and place in therapy 84
Bloodstream infections in critically ill patients with COVID-19 84
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 83
Pregnancy outcomes following exposure to efavirenz-based antiretroviral therapy in the Republic of Congo 83
Tick-borne encephalitis in Europe: a brief update on epidemiology, diagnosis, prevention, and treatment 83
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 83
First report of chronic pulmonary infection by KPC-3-producing and colistin-resistant Klebsiella pneumoniae sequence type 258 (ST258) in an adult patient with cystic fibrosis 81
Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 81
Epidemiology and outcome of Klebsiellapneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-KP) infections in cardiac surgery patients: a brief narrative review 81
Bloodstream infections in internal medicine 79
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after cardiac surgery 77
Impact of negative blood cultures on outcome after surgery for acute infective endocarditis 76
Factors associated with lack of viral suppression at delivery 76
History of schistosomiasis (bilharziasis) in humans: from Egyptian medical papyri to molecular biology on mummies 75
Colistin versus colistin plus meropenem for severe infections 75
Efficacy and Safety of Meropenem–Vaborbactam Versus Best Available Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Without Prior Antimicrobial Failure: A Post Hoc Analysis 75
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 75
Pitfalls of defining combination therapy for carbapenem-resistant Enterobacteriaceae in observational studies 74
A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic 74
Valutazione dei fattori di rischio per lo sviluppo di candidemia dopo interventi di cardiochirurgia maggiore 73
EReply. Diagnostic intricacies and fortuitous treatment approaches for carbapenem-resistant Klebsiella pneumoniae 72
Pharmacokinetics of high-dose extended-infusion meropenem during pulmonary exacerbation in adult cystic fibrosis patients: a case series 71
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 70
Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project 69
The diagnostic conundrum of bacterial infections in cirrhotic patients 69
A look at clinical trial design for new antimicrobials for the adult population 69
Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7) 69
Culture-negative infective endocarditis (CNIE): impact on postoperative mortality 69
Recent advances in the pharmacological management of infections due to multidrug-resistant Gram-negative bacteria 68
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors 68
Early Detection of Sepsis With Machine Learning Techniques: A Brief Clinical Perspective 67
The safety of treatment options for acute bacterial skin and skin structure infections 67
Role of fecal microbiota transplantation in inflammatory bowel disease 66
Comment on: Mortality due to blaKPC klebsiella pneumoniae bacteraemia 65
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP) 65
Reduced Incidence of Carbapenem-Resistant Klebsiella pneumoniae Infections in Cardiac Surgery Patients after Implementation of an Antimicrobial Stewardship Project 65
Diagnosis and Treatment of Candidemia in the Intensive Care Unit 65
Chest physiotherapy: An important adjuvant in critically ill mechanically ventilated patients with COVID-19 65
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 65
Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia 65
Aortic cross-clamp time and cardiopulmonary bypass time: prognostic implications in patients operated on for infective endocarditis 61
Distinct phenotypes require distinct respiratory management strategies in severe COVID-19 61
The COVID-19 insidious trick: Subjective perception of numbers 58
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 58
Isolation of Candida auris from invasive and noninvasive samples of a patient suffering from vascular disease, Italy, July 2019 56
Use of ceftaroline in hospitalized patients with and without covid-19: A descriptive cross-sectional study 56
Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy 55
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study 54
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 54
Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia 53
Machine learning and multidrug-resistant gram-negative bacteria: An interesting combination for current and future research 52
Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients 51
Risk factors for candidemia after open-heart surgery: results from a multicenter case-control study 51
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 51
Totale 9.036
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.891
article - articoli 54.547
book - libri 0
conference - conferenze 551
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 595
Totale 111.584
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.367 0 0 0 139 251 345 364 251 295 404 234 84
2020/20211.676 74 150 178 101 85 89 110 188 157 218 158 168
2021/20221.828 71 50 93 180 84 131 67 351 220 191 107 283
2022/20232.446 218 204 31 233 292 322 85 157 396 145 300 63
2023/20241.676 81 185 44 216 149 249 138 112 81 76 128 217
2024/2025791 151 357 159 124 0 0 0 0 0 0 0 0
Totale 12.197